The Cardiovascular Prevention Program
Cardiovascular Prevention Program at Maria Cecilia Hospital
Maria Cecilia Hospital
150 participants
May 13, 2024
INTERVENTIONAL
Conditions
Summary
Cardiovascular diseases represent one of the main public health problems being the leading cause of morbidity, disability and mortality. In recent decades, the global prevalence and cardiovascular disease mortality has increased, with 23.6 million annual deaths expected by 2030. In Europe, mortality per year is equal to 2.2 million women and 1.9 million men, representing 47% and 37% of all deaths respectively. In Italy, the situation in terms of deaths due to cardiovascular diseases it is in line with the world ranking and European, being responsible for 44% of all deaths. The only interventional or pharmacological approach is neither effective nor sustainable. The most deaths from cardiovascular diseases are due to atherothrombotic events, which are attributable to a series of risk factors, most of which are modifiable. Turns out itself as a targeted action on these factors with the aim of safeguarding the state of health cardiovascular, may represent the best applicable strategy. It is therefore necessary structure and activate prevention programs aimed at the general population and groups of subjects at higher risk.
Eligibility
Inclusion Criteria2
- primary prevention: age ≥ 30 years with a negative history of cardiovascular events
- secondary prevention: age ≥ 30 years with a negative history of cardiovascular events
Exclusion Criteria5
- severe obesity
- high-grade renal failure
- severe and/or dialysis
- oncological disease in active phase
- pregnancy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Assessments of physical activity level and functional capabilities (aerobic capacity, muscular strength and power, flexibility
The 6 Minute Walk Test is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.
Evaluation of the quality of life, the psychological sphere (anxiety, stress, depression) and the quality of sleep
Evaluation of adherence to the Mediterranean diet
Bmode ultrasonography
Measurement of parameters for defining cardiovascular risk and biomarkers.
Evaluation of Gut Microbiota
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06362538